Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hendrik Streefkerk"'
Autor:
Faye M Johnson, Filip Janku, Mohamed A Gouda, Hai T Tran, Jitesh D Kawedia, Debora Schmitz, Hendrik Streefkerk, J Jack Lee, Clark R Andersen, Defeng Deng, Seema Rawal, Pooja A Shah, Adel K El-Naggar, Jason M Johnson, Mitchell J Frederick
Publikováno v:
The Oncologist. 27:1004-e926
Background PI3K/mTOR inhibition leads to apoptosis of NOTCH1-mutant head and neck squamous cell carcinoma (HNSCC) cells. We tested the efficacy of the PI3K/mTOR inhibitor bimiralisib in patients with NOTCH1-mutant HNSCC. Methods Patients with recurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::230b44ce16fbf708715ec0621a79cd8a
https://doi.org/10.1093/oncolo/oyac185
https://doi.org/10.1093/oncolo/oyac185
Publikováno v:
International Journal of Cardiology. 264:118-123
Background PARADIGM-HF demonstrated significant clinical benefits for sacubitril/valsartan (LCZ696, an angiotensin receptor neprilysin inhibitor) versus the angiotensin-converting enzyme inhibitor (ACEI) enalapril in patients with heart failure with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4b72c5b8b8f757bbf809e79341b3f1
https://doi.org/10.1016/j.ijcard.2018.03.121
https://doi.org/10.1016/j.ijcard.2018.03.121
Autor:
Lee, Jea-Young, Cho, Justin, D'Egidio, Francesco, Vignon, Christine, Streefkerk, Hendrik, Kalbermatten, Matthieu de, Garitaonandia, Ibon, Borlongan, Cesar V
Publikováno v:
Stem Cells Translational Medicine; Feb2024, Vol. 13 Issue 2, p177-190, 14p
Publikováno v:
Biotech Finances. 11/22/2021, Issue 965, p2-3. 2p.
Publikováno v:
Biotech Finances. 3/22/2021, Issue 936, p2-3. 2p.
Publikováno v:
Biotech Finances. 10/11/2021, Issue 960, p3-3. 1/7p.
Autor:
Johnson, Faye M, Janku, Filip, Gouda, Mohamed A, Tran, Hai T, Kawedia, Jitesh D, Schmitz, Debora, Streefkerk, Hendrik, Lee, J Jack, Andersen, Clark R, Deng, Defeng, Rawal, Seema, Shah, Pooja A, El-Naggar, Adel K, Johnson, Jason M, Frederick, Mitchell J
Publikováno v:
Oncologist; Dec2022, Vol. 27 Issue 12, p1004-1004, 1p, 7 Charts, 1 Graph
Publikováno v:
Biotech Finances. 3/22/2021, Issue 936, p2-2. 1/3p.